Novel and Emerging Treatments for HR+/HER2-Breast Cancer

Name: Novel and Emerging Treatments for HR+/HER2-Breast Cancer
Start: 2025-01-07T08:00:00-06:00
End: 2025-01-07T17:00:00-06:00
Location: Enduring Material

Enduring Material

PRIME®

1.25 AMA

Related events

It seems we can't find what you're looking for.

For more than 30 years, MECOP has been an ACCME-accredited provider of continuing medical education for physicians.

Novel and Emerging Treatments for HR+/HER2-Breast Cancer

Novel and Emerging Treatments for HR+/HER2-Breast Cancer

Related events

Upcoming Events

Quick Links

Contact Us